EMERGE

EMERGE intends to model the typical behavior of elderly people with medical risks following an integrated approach that uses ambient and unobtrusive sensors, in order to detect deviations from typical behavior, reason on acute disorders, and prevent emergencies.

Ongoing demographical and social changes in most European countries will result in a dramatic increase in emergency situations and missions within the next years. Already today, 44% of emergency medical services (EMS) system resources are dedicated to patients over 70 years.

On the downside, this will result in higher costs for the EMS, which already have to cope with cost restrictions today, in substantially diminished service quality, or, in all probability, in both of these. Unfortunately, a high quality and affordable EMS in case of an emergency is an essential prerequisite for the independent life of elderly people in their preferred environment.

EMERGE tries to improve emergency assistance through early detection and proactive prevention. Ambient and unobtrusive sensing is used to enhance user acceptance. As a consequence, the quality of life for elderly people can increase. Costs for EMS can be leveraged for the elderly as well as for public health and society.

The main goal of EMERGE is to develop and implement a model for recurring behaviors and experiences of elderly people following an integrated approach in order to detect deviations from their typical behavior and to reason on acute disorders in their health condition.

The project's objectives are, therefore, to

  • identify and model the most promising application scenarios for integrated emergency assistance,
  • transfer the emergency model into an application design, identify and engineer suitable ambient information technology,
  • engineer an adequate system architecture and platform, and
  • validate the models and the engineered system in laboratory and field trials.

For further information, please visit:
http://www.emerge-project.eu

Project co-ordinator:
Fraunhofer-Gesellschaft zur Förderung der Angewandten Forschung e.V.

Partners:

  • Siemens Aktiengesellschaft (Germany)
  • Westpfalz-Klinikum GmbH (Germany)
  • Information Society Open to Impairments e-Isotis (Greece)
  • Bay Zoltan Alkalmazott Kutatasi Kozalapitvany (Hungary)
  • Art of Technology AG (Switzerland)
  • Europäisches Microsoft Innovations Center GmbH (Germany)
  • National Centre for Scientific Research "Demokritos" (Greece)
  • Medizinische Universität Graz (Austria)

Timetable: from 01/02/2007 - 31/10/2009

Total cost: € 4.012.690

EC funding: € 2.449.964

Instrument: STREP

Project Identifier: IST-2005-045056

Most Popular Now

ChatGPT Extracts Data for Ischaemic Stro…

In an ischaemic stroke, an artery in the brain is blocked by blood clots and the brain cells can no longer be supplied with blood as a result. Doctors must...

Herefordshire and Worcestershire Health …

Herefordshire and Worcestershire Health and Care NHS Trust has successfully implemented Alcidion's Miya Precision platform to streamline bed management workflow across seven community hospitals in Worcestershire. The trust delivers community...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...

New Horizon Europe Funding Boosts Europe…

The European Commission has announced the launch of new Horizon Europe calls, with a substantial funding pool of over €112 million. These calls are aimed primarily at pioneering projects in...

Cleveland Clinic Study Finds AI can Deve…

Cleveland Clinic researchers developed an artficial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on...

New AI-Technology Estimates Brain Age Us…

As people age, their brains do, too. But if a brain ages prematurely, there is potential for age-related diseases such as mild-cognitive impairment, dementia, or Parkinson's disease. If "brain age...

With Huge Patient Dataset, AI Accurately…

Scientists have designed a new artificial intelligence (AI) model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease. The model...

Radboud University Medical Center and Ph…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Radboud University Medical Center have signed a hospital-wide, long-term strategic partnership that delivers the latest patient monitoring...

GPT-4, Google Gemini Fall Short in Breas…

Use of publicly available large language models (LLMs) resulted in changes in breast imaging reports classification that could have a negative effect on patient management, according to a new international...

ChatGPT fails at heart risk assessment

Despite ChatGPT's reported ability to pass medical exams, new research indicates it would be unwise to rely on it for some health assessments, such as whether a patient with chest...

Study Shows ChatGPT Failed when Challeng…

With artificial intelligence (AI) poised to become a fundamental part of clinical research and decision making, many still question the accuracy of ChatGPT, a sophisticated AI language model, to support...

Virtual Reality Shows Promise in Fightin…

A new study published in JMIR Mental Health sheds light on the promising role of virtual reality (VR) in treating major depressive disorder (MDD). Titled "Examining the Efficacy of Extended...